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derived from lactic acid bacteria (Lactobacillus sakei)
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Saikab; Takahiro Nagatakeb; Ayu Matsunagab; Jun 
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Introduction: Intestinal bacteria and probiotics 
such as lactic acid bacteria are involved in the devel-
opment and regulation of gut immunity. We previously 
found that Lactobacillus sakei subsp. sakei NBRC 
15893, a lactic acid bacterium, enhances immunoglo-
bulin A (IgA) production in mouse intestinal Peyer’s 
patch (PP) cells. IgA plays a key role in preventing 
pathogenic infections and maintaining the gut environ-
ment. Here, we report on the IgA-enhancing effects of 
membrane vesicles (MVs) derived from the same bac-
terial strain as well as the on mechanisms underlying 
that effect.
Methods: Lactobacillus sakei NBRC 15893 was cul-
tured in MRS medium. The broth was centrifuged 
(8,500 × g, 5 min) and then filtered (0.22 μm). MVs 
were collected by ultracentrifugation (100,000 × g, 1 h) 
and purified by density gradient ultracentrifugation. PP 
cells and bone marrow-derived dendritic cells (DCs) 
were prepared from BALB/c mice. IgA concentration 
was determined by ELISA.
Results: MVs enhanced IgA production from PP 
cells, and the MV-mediated enhancement was abol-
ished by the depletion of DCs or the neutralization of 
Toll-like receptor (TLR) 2, indicating that MVs stimu-
late DCs in PP cells via TLR2. MVs upregulated mRNA 
expression of inflammatory cytokines (e.g., interleukin 
[IL]-6), inducible nitric oxide synthase (iNOS), and 
retinal dehydrogenase 2 (RALDH) in bone marrow- 
derived DCs. Inhibition of iNOS and RALDH or neu-
tralization of IL-6 inhibited the MV-mediated effect in 
IgA production in PP cells, indicating that in PP cells, 
IgA production secondary to MVs stimulation is 
dependent on NO, retinoic acid, and IL-6 production. 
Furthermore, MVs were found into the subepithelial 
dome region of PPs, where DCs reside, indicating that 
MVs might also regulate the intestinal immune system 
in vivo.
Summary/Conclusion: We hypothesize that L. sakei 
NBRC 15893–derived MVs enhance IgA production in 
PP cells via three processes: 1) TLR2-mediated DCs 
activation, 2) NO – and retinoic acid–mediated IgA 
class switch recombination in B cells, and 3) IL-6– 
mediated B cells’ differentiation into plasma cells. Our 
results show that when assessing the effects of probio-
tics, it is necessary to consider not only the effects of 
bacteria per se but also of bacteria-derived MVs.
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Introduction: Tumour-associated macrophages 
(TAMs) play a key role in promoting tumour progres-
sion, by exerting an immunosuppressive phenotype 
associated with M2 polarization and with the expres-
sion of CD204 and programmed cell death ligand 1 
(PD-L1). It is well known that tumour-derived extra-
cellular vesicles (TEVs) play a pivotal role in the 
tumour microenvironment, influencing TAM beha-
viour. The study was aimed to examine the effect of 
TEVs derived from colon cancer and multiple mye-
loma cells on macrophage functions.
Methods: Non-polarized macrophages (M0) differ-
entiated from THP-1 cells were co-cultured, for 3 up to 
48 hours, with TEVs derived from a colon cancer cell 
line, SW480, and multiple myeloma cell line, MM1.S. 
The expression of M2 and TAM markers (respectively 
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CD163 and CD204) as well as of PD-L1 and 
Interleukin 6 (IL6) were evaluated at mRNA and pro-
tein level. The apoptotic rate of CD3 + T cells co- 
cultured with TEV-treated M0 macrophages was ana-
lysed by FACS.
Results: Our results indicate that TEVs can sig-
nificantly upregulate the expression of surface mar-
kers of M2-like phenotype (CD163) and TAM 
(CD204) as well as of PD-L1, inducing macrophages 
to acquire an immunosuppressive phenotype. In par-
allel, we found that TEVs were also able to induce 
a significant increase of IL6 expression at both 
mRNA and protein levels and to activate the 
STAT3 signalling pathway. Since PD-1/PD-L1 axis 
is involved in the inhibition of T cells, we assessed 
the ability of macrophages treated with TEVs to 
affect T cell viability. We found that CD3 + T cells 
co-cultured with TEVs-treated M0 showed an 
increase of their apoptotic rate in comparison to 
CD3 + T cells grown in the presence of untreated 
macrophages.
Summary/Conclusion: Cumulatively, these preli-
minary data suggest that TEVs contribute to the immu-
nosuppressive status of TAMs, promoting tumour 
growth and progression.
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